Glomerular size and the association of focal glomerulosclerosis in long- surviving human renal allografts


2007 JASN IMPACT FACTOR 7.111	HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Bhathena, D. B.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Bhathena, D. B.

REGULAR ARTICLES

Glomerular size and the association of focal glomerulosclerosis in long- surviving human renal allografts

DB Bhathena
Department of Pathology, Wayne State University, Detroit, MI 48201.

This biopsy study exploits the unique opportunity offered by long- surviving human renal allografts to analyze the effects of nephronopenia-induced glomerular hypertrophy on the association of focal glomerulosclerosis. Methods include glomerular morphometry and analysis of variance. Only allografts with focal glomerulosclerosis detected after 3 yr posttransplantation (Group TxFGS > 2 yr) have a group mean glomerular diameter (203.1 microns +/- SE (mean) 10.36) significantly larger (P < 0.05) than that of allografts biopsied beyond 2 yr posttransplantation but without focal glomerulosclerosis (Group No TxFGS > 2 yr; 158.3 microns +/- SE (mean) 8.32), allografts biopsied within 2 yr of transplantation with (Group TxFGS < 2 yr; 165.3 microns +/- SE (mean) 5.35) or without (Group NoTxFGS < 2 yr; 155.8 microns +/- SE (mean) 5.53) focal glomerulosclerosis, or allograft diameters at transplantation (Group CTx; 148.3 microns +/- SE (mean) 5.66). However, the increase is approximately 37% over that at transplantation, significantly less than the increase of approximately 70% attained by congenitally nephronopenic native kidneys (P < 0.50) with focal glomerulosclerosis (Group CNP; 264.4 microns +/- SE (mean) 11.01) over their controls (Group CN; 154.8 microns +/- SE (mean) 4.46). This observation suggests that the nephronopenic allograft has a curtailed ability for glomerular hypertrophy when compared with congenitally nephronopenic native kidneys and may explain the association of focal glomerulosclerosis in long-surviving renal homografts at a significantly smaller glomerular diameter. Although smaller, this appears to be the maximal glomerular dimension attained by long- surviving nephronopenic homografts in the absence of intrinsic glomerular disease (excluding focal glomerulosclerosis). Thus, these results are in accord with and offer further support for the general hypothesis that focal glomerulosclerosis develops in maximally hypertrophied glomeruli.

This article has been cited by other articles:

X. Fulladosa, F. Moreso, J. A. Narvaez, J. M. Grinyo, and D. Seron
Estimation of Total Glomerular Number in Stable Renal Transplants
J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2662 - 2668.
[Abstract] [Full Text] [PDF]

K. Oka, E. Imai, T. Moriyama, Y. Akagi, A. Ando, M. Hori, A. Okuyama, K. Toki, M. Kyo, Y. Kokado, et al.
A clinicopathological study of IgA nephropathy in renal transplant recipients: beneficial effect of angiotensin-converting enzyme inhibitor
Nephrol. Dial. Transplant., May 1, 2000; 15(5): 689 - 695.
[Abstract] [Full Text] [PDF]

HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

				K. Oka, E. Imai, T. Moriyama, Y. Akagi, A. Ando, M. Hori, A. Okuyama, K. Toki, M. Kyo, Y. Kokado, et al. A clinicopathological study of IgA nephropathy in renal transplant recipients: beneficial effect of angiotensin-converting enzyme inhibitor Nephrol. Dial. Transplant., May 1, 2000; 15(5): 689 - 695. [Abstract] [Full Text] [PDF]